Last reviewed · How we verify

NCT03805854

Modulating Pain Using Transcranial Alternating Stimulation (tACS) in Healthy Human Subjects

Completed NA Last updated 4 June 2020
What this trial tests

NA trial testing 10 Hz tACS of the bilateral somatosensory cortex in Experimental Pain in Healthy Human Subjects in 39 participants. Completed in 23 October 2019.

Timeline
15 April 2019
Primary endpoint
23 October 2019
23 October 2019

Quick facts

Lead sponsorTechnical University of Munich
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment39
Start date15 April 2019
Primary completion23 October 2019
Estimated completion23 October 2019
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Technical University of Munich

Who can join

Adults 18 to 65, any sex, with Experimental Pain in Healthy Human Subjects. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pain is a highly complex and subjective phenomenon which results from the dynamic integration of sensory and contextual (i.e. cognitive, emotional, and motivational) processes. Recent evidence suggests that neural oscillations and their synchronization between different brain areas might form the basis of these integrative functions. When investigating tonic experimental pain lasting for several minutes, for example, objective stimulus intensity is inversely related to alpha (8-13 Hz) and beta (13-30 Hz) oscillations in early somatosensory areas, while subjective pain intensity is positively associated with gamma (30-100 Hz) oscillations in prefrontal cortex. Yet, with a few exemptions, reported links between oscillatory brain activity and pain have mostly been established by correlative approaches which do not allow to infer causality. The current project aims at comprehensively investigating the causal role of neural oscillations for tonic experimental pain in healthy human subjects. To this end, transcranial alternating current stimulation (tACS) will be employed to modulate oscillatory brain activity in alpha and gamma frequency bands and investigate effects of this manipulation on pain perception and pain-related autonomic responses. Using an established tonic pain stimulation protocol and a double-blind, sham-controlled design, effects of tACS of somatosensory as well as prefrontal brain areas will be investigated. Results promise to elucidate the neural mechanisms underlying tonic experimental pain by testing the mechanistic role of neural oscillations in different aspects of pain processing. Furthermore, they might contribute to the development of urgently needed new treatment approaches for chronic pain using neuromodulatory methods.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Modulating Brain Rhythms of Pain Using Transcranial Alternating Current Stimulation (tACS) - A Sham-Controlled Study in Healthy Human Participants.
    May ES, Hohn VD, Nickel MM, Tiemann L, et al · · 2021 · cited 16× · PMID 33845173 · DOI 10.1016/j.jpain.2021.03.150

Verify or expand the search:

Other Technical University of Munich trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03805854.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing